Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An update on the general management approach to common vasculitides.

Literature DB >> 33199323

An update on the general management approach to common vasculitides.

Mooikhin Hng¹, Sizheng S Zhao², Robert J Moots³.

Abstract

Primary systemic vasculitides (PSV) are multisystem diseases associated with high morbidity and mortality, particularly if not treated in a timely manner. In recent decades, clinical trials have delivered considerable evidence to underpin optimal diagnostic and therapeutic approaches. This article provides a brief overview of PSV in adults, focusing on the latest updates and recommendations for the management of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis. © Royal College of Physicians 2020. All rights reserved.

Entities: Disease

Keywords: ANCA; Vasculitis; giant cell arteritis; rituximab; tocilizumab

Mesh：

Year: 2020 PMID： 33199323 PMCID： PMC7687327 DOI： 10.7861/clinmed.2020-0747

Source DB: PubMed Journal: Clin Med (Lond) ISSN： 1470-2118 Impact factor: 2.659

46 in total

1. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

Authors: Anthea Craven; Joanna Robson; Cristina Ponte; Peter C Grayson; Ravi Suppiah; Andrew Judge; Richard Watts; Peter A Merkel; Raashid A Luqmani
Journal: Clin Exp Nephrol Date: 2013-08-31 Impact factor: 2.801

2. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

Authors: Bernhard Hellmich; Ana Agueda; Sara Monti; Frank Buttgereit; Hubert de Boysson; Elisabeth Brouwer; Rebecca Cassie; Maria C Cid; Bhaskar Dasgupta; Christian Dejaco; Gulen Hatemi; Nicole Hollinger; Alfred Mahr; Susan P Mollan; Chetan Mukhtyar; Cristina Ponte; Carlo Salvarani; Rajappa Sivakumar; Xinping Tian; Gunnar Tomasson; Carl Turesson; Wolfgang Schmidt; Peter M Villiger; Richard Watts; Chris Young; Raashid Ahmed Luqmani
Journal: Ann Rheum Dis Date: 2019-07-03 Impact factor: 19.103

3. High-Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study.

Authors: Maxime Rhéaume; Ryan Rebello; Christian Pagnoux; Simon Carette; Marie Clements-Baker; Violette Cohen-Hallaleh; David Doucette-Preville; B Stanley Jackson; Samih Salama Sargious Salama; George Ioannidis; Nader A Khalidi
Journal: Arthritis Rheumatol Date: 2017-01 Impact factor: 10.995

4. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.

Authors: Tanaz A Kermani; Jean Schmidt; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Eric L Matteson; Kenneth J Warrington
Journal: Semin Arthritis Rheum Date: 2011-11-25 Impact factor: 5.532

5. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.

Authors: Mona Parikh; Neil R Miller; Andrew G Lee; Peter J Savino; M Noel Vacarezza; Wayne Cornblath; Eric Eggenberger; Aileen Antonio-Santos; Karl Golnik; Randy Kardon; Michael Wall
Journal: Ophthalmology Date: 2006-08-01 Impact factor: 12.079

6. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Authors: Benjamin Terrier; Christian Pagnoux; Élodie Perrodeau; Adexandre Karras; Chahera Khouatra; Olivier Aumaître; Pascal Cohen; Olivier Decaux; Hélène Desmurs-Clavel; François Maurier; Pierre Gobert; Thomas Quémeneur; Claire Blanchard-Delaunay; Bernard Bonnotte; Pierre-Louis Carron; Eric Daugas; Marize Ducret; Pascal Godmer; Mohamed Hamidou; Olivier Lidove; Nicolas Limal; Xavier Puéchal; Luc Mouthon; Philippe Ravaud; Loïc Guillevin
Journal: Ann Rheum Dis Date: 2018-05-03 Impact factor: 19.103

7. Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis.

Authors: Emma Rubenstein; Carla Maldini; Solange Gonzalez-Chiappe; Sylvie Chevret; Alfred Mahr
Journal: Rheumatology (Oxford) Date: 2020-05-01 Impact factor: 7.580

8. Trial of Tocilizumab in Giant-Cell Arteritis.

Authors: John H Stone; Katie Tuckwell; Sophie Dimonaco; Micki Klearman; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Georg Schett; Hendrik Schulze-Koops; Robert Spiera; Sebastian H Unizony; Neil Collinson
Journal: N Engl J Med Date: 2017-07-27 Impact factor: 91.245

An update on the general management approach to common vasculitides.

1. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).

2. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

3. High-Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study.

4. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.

5. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.

6. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

7. Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis.

8. Trial of Tocilizumab in Giant-Cell Arteritis.

Review 9. Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.

Review 10. A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus Classification.

1. General management approach to common vasculitides.

2. JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides.